SYMBYX is an Australian company developing light therapies and laser devices to promote wellness and manage intractable conditions such as Parkinson's, Fibromyalgia, IBD/IBS, Arthritis, Chronic Pain... Founded in 2019 by a diverse group of consumer, medical and biotech professionals, we are a privately-held, early-stage company with partners and investors in the US, Sweden, Germany and Australia. Our medical grade laser and light devices use photobiomodulation to stimulate cell recovery and reduce chronic pain and inflammation, often via the gut microbiome and the gut-brain axis, but also via the brain directly. Our super-pulsed infrared and red light devices and lasers are backed by peer reviewed medical research. Please see clinical trial results published in BMC Neurology Journal on 2 July 2021, "Improvements in clinical signs of Parkinson's disease using photobiomodulation." Patients showed significant improvements in cognition, movement and mood, and have sustained those improvements for over 3 years now. We are currently involved in large-scale randomised, placebo control, scientific trials in Canada and Australia, and in discussion with several further universities and prominent photobiomodulation researchers. Our products are CE/ARTG listed and backed by a team of qualified clinicians worldwide who work with customers directly and also , made in Sweden and Australia, and come with a 2 year warranty. We ship worldwide using DHL Express.